What is MRLN's Value Score?

MERLIN, INC. (MRLN) has a StockPik Value Score of 42 out of 100 — a mid-range score, indicating moderate value characteristics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is MRLN's Piotroski F-Score?

MERLIN, INC. (MRLN) has a Piotroski F-Score of 2 out of 9 — a weak score indicating financial deterioration across multiple criteria. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

What is MRLN's Piotroski F-Score?

MRLN's Piotroski F-Score is 2 out of 9, indicating weak financial health and possible deterioration. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is MRLN (MERLIN, INC.) undervalued?

MRLN scores 42/100 on StockPik's Value Score.

Back to Screener

MERLIN, INC. (MRLN)

NASDAQ Small Cap

$5.63

Market Cap: $569M

Data as of Jun 30, 2026 (TTM)

Price History

Mar 20, 2026 — Sep 10, 2026

Investment Snapshot

Piotroski F-Score 2/9 — signs of financial weakness
Negative net margin (-2,042.3%) — currently unprofitable

MERLIN, INC. (MRLN) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $569 million . Key value metrics: Piotroski F-Score 2 out of 9 .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

—

P/B Ratio

—

EPS

$-1.45

Div. Yield

—

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Data sourced from SEC EDGAR and Polygon.io. Methodology.

MERLIN, INC. — Fundamental Analysis Summary

StockPik's composite Value Score for MRLN is 42/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

MRLN reports a moderate gross margin of 26.3% and a negative operating margin of -885.8%.

How is the Value Score calculated?

Read our full methodology →

What is the Piotroski F-Score?

The 9-point financial health score explained, with worked examples →

MRKR — Marker Therapeutics, Inc. - Common Stock

Moderna, Inc. - Common Stock — MRNA